Nektar Therapeutics (NKTR) Net Margin (QoQ) (2010 - 2026)
Nektar Therapeutics (NKTR) Net Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39,556.00 |
| Dec 31, 2025 | 29,499.00 |
| Sep 30, 2025 | 5,409.00 |
| Jun 30, 2025 | 9,295.00 |
| Mar 31, 2025 | -55,366.00 |
| Dec 31, 2024 | 26,348.00 |
| Sep 30, 2024 | 6,932.00 |
| Jun 30, 2024 | -5,285.00 |
| Mar 31, 2024 | 610.00 |
| Dec 31, 2023 | 1,368.00 |
| Sep 30, 2023 | 5,954.00 |
| Jun 30, 2023 | 38,513.00 |
| Mar 31, 2023 | -72,612.00 |
| Dec 31, 2022 | 34,155.00 |
| Sep 30, 2022 | 48,699.00 |
| Jun 30, 2022 | -37,277.00 |
| Mar 31, 2022 | -187,880.00 |
| Dec 31, 2021 | 203,510.00 |
| Sep 30, 2021 | -7,741.00 |
| Jun 30, 2021 | 7,695.00 |